Zeenat Qureshi Stroke Research Center, University of Minnesota, Minneapolis, Minnesota, USA; Department of Neurosurgery, University of Minnesota, Minneapolis, Minnesota, USA.
Zeenat Qureshi Stroke Research Center, University of Minnesota, Minneapolis, Minnesota, USA.
World Neurosurg. 2014 Nov;82(5):678-83. doi: 10.1016/j.wneu.2013.07.079. Epub 2013 Aug 1.
Postthrombolytic intracerebral hemorrhage (ICH) is an infrequent occurrence in patients with acute ischemic stroke. There is controversy surrounding the value of neurosurgical treatment of symptomatic hematomas in these patients and whether availability of neurosurgical treatment is a necessary prerequisite for administration of thrombolytic agents. We report the frequency and outcomes of patients who undergo craniotomy for postthrombolytic ICH.
Patients with acute ischemic stroke who experienced postthrombolytic ICH were identified using the Nationwide Inpatient Sample from 2002-2010 and International Classification of Diseases, 9th Revision, Clinical Modification codes. Patients were divided into patients who received craniotomy and patients who received medical management alone. Discharge destination and mortality were primary endpoints.
An estimated 7607 patients experienced postthrombolytic ICH; 125 (1.6%) patients underwent craniotomy, and 7482 patients (98.4%) received medical treatment alone. Patients in the craniotomy group were younger (53.7 years old ± 36 vs. 72.4 years old ± 29, P = 0.09) and were frequently in the extreme severity All Patient Refined Diagnosis Related Group category compared with patients in the medical management group (92.2% vs. 55.5%, P = 0.001). The mean length of stay was also longer in the craniotomy group (21.5 days vs. 10 days, P < 0.0001). In-hospital mortality was greater in the medical management group (30.5% vs. 24.2%, P = 0.5). After adjusting for age, gender, and All Patient Refined Diagnosis Related Group severity index, the odds ratios of in-hospital mortality, discharge to extended care facility, and discharge to home or self-care were 0.8 (95% confidence interval [CI] 0.3-2.0, P = 0.5), 5.4 (95% CI 0.6-52.0, P = 0.1), and 0.2 (95% CI 0.02-1.8, P = 0.1) for the craniotomy group compared with the medical management group.
Emergent craniotomy for postthrombolytic ICH in patients with acute stroke is a salvage treatment offered to a small proportion of patients. Although biases introduced by patient selection cannot be excluded in our analysis, the excessively high rates of death or disability associated with surgical evacuation limit the value of such a procedure in current practice.
溶栓后颅内出血(ICH)在急性缺血性脑卒中患者中较为少见。对于这些患者,症状性血肿的神经外科治疗的价值以及神经外科治疗的可用性是否是溶栓药物应用的必要前提存在争议。我们报告了接受溶栓后 ICH 开颅手术的患者的频率和结局。
使用 2002-2010 年全国住院患者样本和国际疾病分类,第 9 版临床修正版代码,确定发生溶栓后 ICH 的急性缺血性脑卒中患者。将患者分为接受开颅手术的患者和仅接受药物治疗的患者。出院去向和死亡率是主要终点。
估计有 7607 例患者发生溶栓后 ICH;125 例(1.6%)患者接受开颅手术,7482 例(98.4%)患者仅接受药物治疗。开颅手术组的患者更年轻(53.7 岁±36 岁与 72.4 岁±29 岁,P=0.09),且与药物治疗组相比,经常处于极高严重程度的所有患者细化诊断相关组类别(92.2%与 55.5%,P=0.001)。开颅手术组的平均住院时间也更长(21.5 天与 10 天,P<0.0001)。药物治疗组的院内死亡率更高(30.5%与 24.2%,P=0.5)。在校正年龄、性别和所有患者细化诊断相关组严重程度指数后,开颅手术组的院内死亡率、出院至长期护理机构、出院至家庭或自理的比值比分别为 0.8(95%置信区间[CI]0.3-2.0,P=0.5)、5.4(95%CI0.6-52.0,P=0.1)和 0.2(95%CI0.02-1.8,P=0.1)。
急性脑卒中溶栓后 ICH 的紧急开颅手术是为一小部分患者提供的挽救性治疗。尽管我们的分析中不能排除因患者选择而产生的偏倚,但与手术清除相关的过高死亡率或残疾率限制了该手术在当前实践中的应用价值。